APA (7th ed.) Citation

J, L., DX, Z., JH, L., N, Z., ZL, Y., XD, X., . . . Y, S. (2026). Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma. Nature, 652(8110), 731. https://doi.org/10.1038/s41586-026-10244-w

Chicago Style (17th ed.) Citation

J, Lv, et al. "Risk-adaptive Therapy Guided by Dynamic CtDNA in Nasopharyngeal Carcinoma." Nature 652, no. 8110 (2026): 731. https://doi.org/10.1038/s41586-026-10244-w.

MLA (9th ed.) Citation

J, Lv, et al. "Risk-adaptive Therapy Guided by Dynamic CtDNA in Nasopharyngeal Carcinoma." Nature, vol. 652, no. 8110, 2026, p. 731, https://doi.org/10.1038/s41586-026-10244-w.